Barclays Hikes Atlassian Price Target to $112: Annual Recurring Revenue Disclosure Validates the Enterprise Bull Case

Barclays raised its price target on Atlassian (NASDAQ:TEAM | TEAM Price Prediction) stock to $112 from $106 while keeping an Overweight rating, declaring that the company’s new annual recurring revenue (ARR) disclosure validates the improving trajectory of its growth algorithm. The price target raise follows Atlassian’s investor forum, where management spotlighted clear enterprise momentum behind the Jira and Confluence maker. For long-term investors, the analyst upgrade signals deepening Wall Street confidence in the firm’s enterprise pivot.

Atlassian stock has rallied sharply since last week’s Q3 FY2026 results, climbing 26% over the past week to $90.99. Shares still sit far below the 52-week high of $232.36, framing the Barclays note as a recovery thesis rather than a momentum chase. For broader context on software sector positioning, see our recent coverage of top software stocks.

The Analyst’s Case

For a SaaS business, ARR is often the cleanest forward-looking growth indicator because it strips out revenue-recognition noise and reflects the run-rate value of the customer base. By choosing to disclose its ARR, Atlassian is inviting the market to measure it on a metric where the trajectory is accelerating.

The supporting data is concrete. Atlassian’s Service Collection eclipsed $1 billion in ARR, growing over 30% year-over-year, with enterprise ARR inside that collection growing over 50%. CEO Mike Cannon-Brookes asserted that the milestone “continues to take share and reinforce our conviction in the long-term growth opportunity of the Atlassian System of Work.”

Company Snapshot

Atlassian builds enterprise collaboration software including Jira, Confluence, Jira Service Management, Rovo, Loom, Bitbucket, and Trello, serving 85% of the Fortune 500. The aggressive sunset of server-deployed software pushed customers toward cloud, creating near-term revenue noise but cleaner long-term economics.

Atlassian’s Q3 FY2026 revenue reached $1.79 billion, up 32% year over year, with remaining performance obligations of $4 billion, up 37%. The customer mix now includes more than 600 customers contributing $1 million-plus in ARR.

Why the Move Matters Now

Atlassian’s valuation looks more reasonable than it did a year ago, with TEAM stock trading at a forward P/E ratio of 17x and price-to-sales of 4x. Management is also returning capital aggressively, repurchasing 11.8 million shares for $1 billion in Q3, with $2.2 billion remaining on the buyback authorization.

Enterprise momentum is the second pillar for Atlassian. Larger contract values, longer terms, and stickier relationships are showing up in net revenue retention (NRR) maintained north of 120% and competitive displacements from legacy IT service management (ITSM) rivals like ServiceNow at record levels.

What It Means for Your Portfolio

The bull case for Atlassian stock rests on platform breadth, AI-driven seat expansion, and enterprise wallet share. Rovo customers are growing ARR at roughly 2x the rate of non-Rovo customers, with AI credit usage growing 20%-plus month over month.

The bear case is real: rich valuation versus GAAP losses, AI-driven workflow disruption risk, and competitive intensity from Microsoft, GitLab, Asana, and Monday.com. Atlassian also flagged that Data Center revenue growth will meaningfully decelerate in FY27 as the end-of-life recognition tailwind laps.

Prudent investors weighing TEAM stock might consider a measured position size. The Barclays price target raise validates the enterprise thesis, yet the multi-year journey through cloud migration and stock-based compensation debates argues for patience over conviction sizing.